Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis ; volume:14 ; number:1 ; day:10 ; month:3 ; year:2021 ; pages:1-7 ; date:12.2021
BMC Research Notes / Biomed Central; 14, Heft 1 (10.3.2021), 1-7, 12.2021
- Creator
-
Tamai, Iradj Ashrafi
Pakbin, Babak
Fasaei, Bahar Nayeri
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-021-05498-8
- URN
-
urn:nbn:de:101:1-2021042920010627549536
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tamai, Iradj Ashrafi
- Pakbin, Babak
- Fasaei, Bahar Nayeri
- SpringerLink (Online service)
Other Objects (12)
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Candida albicans and Antifungal Peptides
Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Antifungal activity of MAF-1A peptide against Candida albicans
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity
Moxidectin elevates Candida albicans ergosterol levels to synergize with polyenes against oral candidiasis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Candida albicans and Antifungal Peptides
Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Antifungal activity of MAF-1A peptide against Candida albicans
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity
Moxidectin elevates Candida albicans ergosterol levels to synergize with polyenes against oral candidiasis
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Candida albicans and Antifungal Peptides
Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Antifungal activity of MAF-1A peptide against Candida albicans
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity